Known targets — ChEMBL curated mechanism
EGFREPHA1EPHA10EPHA2EPHA3EPHA4EPHA5EPHA6EPHA7EPHA8EPHB1EPHB2EPHB3EPHB4EPHB6ERBB2ERBB3ERBB4FLT1FLT4KDRPTK6RETSRCTEK
The experimentally established mechanism targets of Vandetanib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR known ✓ | P00533 | 16/20 | 1.00 |
| ▸ | KDR known ✓ | P35968 | 13/20 | 1.00 |
| ▸ | FLT1 known ✓ | P17948 | 11/20 | 1.00 |
| ▸ | FLT4 known ✓ | P35916 | 11/20 | 1.00 |
| ▸ | RET known ✓ | P07949 | 3/20 | 1.00 |
| ▸ | EPHA2 known ✓ | P29317 | 3/20 | 1.00 |
| ▸ | EPHB4 known ✓ | P54760 | 3/20 | 1.00 |
| ▸ | TEK known ✓ | Q02763 | 2/20 | 1.00 |
| ▸ | EPHB6 known ✓ | O15197 | 1/20 | 1.00 |
| ▸ | ERBB2 known ✓ | P04626 | 1/20 | 1.00 |
| ▸ | SRC known ✓ | P12931 | 1/20 | 1.00 |
| ▸ | EPHA1 known ✓ | P21709 | 1/20 | 1.00 |
| ▸ | ERBB3 known ✓ | P21860 | 1/20 | 1.00 |
| ▸ | EPHA3 known ✓ | P29320 | 1/20 | 1.00 |
| ▸ | EPHA8 known ✓ | P29322 | 1/20 | 1.00 |
| ▸ | EPHB2 known ✓ | P29323 | 1/20 | 1.00 |
| ▸ | EPHA5 known ✓ | P54756 | 1/20 | 1.00 |
| ▸ | EPHB1 known ✓ | P54762 | 1/20 | 1.00 |
| ▸ | EPHA4 known ✓ | P54764 | 1/20 | 1.00 |
| ▸ | PTK6 known ✓ | Q13882 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vandetanib SCHEMBL9044 | 1.00 | EGFR (1.00) | EGFRKDRFGFR1FLT1FLT4 | |
| Vandetanib SCHEMBL29352879 | 1.00 | EGFR (1.00) | EGFRKDRFGFR1FLT1FLT4 | |
| Vandetanib SCHEMBL1614458 | 0.99 | EGFR (1.00) | EGFRKDRFGFR1FLT1FLT4 | |
| Vandetanib SCHEMBL4637084 | 0.99 | EGFR (0.98) | EGFRKDRFGFR1FLT1FLT4 | |
| Vandetanib SCHEMBL1783178 | 0.94 | EGFR (0.89) | EGFRKDRFGFR1FLT1FLT4 | |
| SCHEMBL4544070 | 0.93 | EGFR (0.87) | EGFRKDRFGFR1FLT1FLT4 | |
| Vandetanib SCHEMBL1614619 | 0.93 | EGFR (0.86) | EGFRKDRFGFR1FLT1FLT4 | |
| SCHEMBL26359052 | 0.92 | EGFR (0.85) | EGFRKDRFGFR1FLT1FLT4 | |
| SCHEMBL12534441 | 0.92 | EGFR (0.85) | EGFRKDRFGFR1FLT1FLT4 | |
| SCHEMBL27218180 | 0.91 | EGFR (1.00) | EGFRKDRFGFR1FLT1FLT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108159050-B | Application of vandetanib in pharmacy and pharmaceutical preparation | 武汉轻工大学 | 2020-11-24 | — | — | CN | disclosed |
| CN-108159050-A | Application and pharmaceutical preparation of the Vande Thani in pharmacy | 武汉轻工大学 | 2018-06-15 | — | — | CN | disclosed |